RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Drug-Related Side Effects and Adverse Reactions |
|
Accession: | DOID:9006810
|
browse the term
|
Definition: | Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. |
Synonyms: | exact_synonym: | Adverse Drug Reaction; Adverse Drug Reactions; Drug Side Effect; Drug Side Effects; Drug Toxicities; adverse drug event; adverse drug events; drug toxicity; side effects of drugs |
| related_synonym: | Brain pseudoatrophy, reversible, valproate-induced, susceptibility to |
| primary_id: | MESH:D064420 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18381794 PMID:20563569 PMID:21064136 PMID:24502637 PMID:25007187 PMID:28193520 PMID:32387182 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18256692 |
|
NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
|
|
G |
Abcc12 |
ATP binding cassette subfamily C member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18466103 |
|
NCBI chr19:21,541,324...21,612,757
Ensembl chr19:21,541,742...21,612,527
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20216337 PMID:23222202 PMID:25007187 PMID:32387182 |
|
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23222202 |
|
NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21064136 PMID:32387182 |
|
NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
|
|
G |
Ache |
acetylcholinesterase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27083141 |
|
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
|
|
G |
Adora1 |
adenosine A1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15641640 |
|
NCBI chr13:51,042,111...51,076,913
Ensembl chr13:51,042,248...51,076,852
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15641640 |
|
NCBI chr20:14,265,251...14,282,873
Ensembl chr20:14,265,252...14,282,873
|
|
G |
Afm |
afamin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr14:19,078,678...19,132,212
Ensembl chr14:19,078,680...19,132,208
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr11:81,711,269...81,717,594
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24361871 PMID:28885000 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 5:78,975,690...78,986,021
Ensembl chr 5:78,975,678...78,985,990
|
|
G |
Apob |
apolipoprotein B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31186542 |
|
NCBI chr 6:33,176,826...33,216,381
Ensembl chr 6:33,176,778...33,224,997
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24712521 |
|
NCBI chr20:21,713,900...21,881,193
Ensembl chr20:21,564,975...21,880,715
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
|
IEP |
protein:increased expression:plasma (rat) |
RGD |
PMID:20544730 |
RGD:4140449 |
NCBI chr 3:10,327,411...10,375,847
Ensembl chr 3:10,327,414...10,375,826
|
|
G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16947783 |
|
NCBI chr 9:78,862,013...78,882,061
Ensembl chr 9:78,862,013...78,882,060
|
|
G |
B2m |
beta-2 microglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 3:114,087,287...114,093,311
Ensembl chr 3:114,087,287...114,093,309
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:3111302 |
|
NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395
|
|
G |
C3 |
complement C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30552955 |
|
NCBI chr10:14,730,932...14,789,201
Ensembl chr10:14,730,941...14,788,617
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
|
ISO |
associated with colon cancer |
RGD |
PMID:22020760 |
RGD:15097511 |
NCBI chr 5:156,876,706...156,878,486
Ensembl chr 5:156,876,706...156,878,486
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355
|
|
G |
Ces2h |
carboxylesterase 2H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19931604 |
|
NCBI chr19:37,052,555...37,067,176
Ensembl chr19:37,052,556...37,067,156
|
|
G |
Clu |
clusterin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24361871 PMID:28885000 |
|
NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
|
|
G |
Commd1 |
copper metabolism domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23583003 |
|
NCBI chr14:107,664,321...107,759,974
Ensembl chr14:107,664,255...107,760,191
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
|
|
G |
Csf2 |
colony stimulating factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7960606 |
|
NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:7692001 PMID:27737899 PMID:31557154 |
|
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
Cst3 |
cystatin C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 3:143,219,671...143,223,544
Ensembl chr 3:143,219,686...143,223,615
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10445756 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27736846 |
|
NCBI chr 1:147,236,480...147,307,988
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23609392 |
|
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18990727 |
|
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21064136 |
|
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
|
|
G |
Dip2b |
disco-interacting protein 2 homolog B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr 7:141,702,034...141,878,945
Ensembl chr 7:141,702,038...141,879,951
|
|
G |
Epha7 |
Eph receptor A7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30357299 |
|
NCBI chr 5:43,602,744...43,761,198
Ensembl chr 5:43,603,043...43,757,549
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26165641 |
|
NCBI chr15:42,757,241...42,794,211
Ensembl chr15:42,757,235...42,794,279
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
treatment |
ISO |
associated with Breast Neoplasms;DNA:SNP: :p.Q504K (human) associated with Leukemia, Myeloid, Acute |
RGD |
PMID:25495407, PMID:17197435 |
RGD:11252168, RGD:11252178 |
NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
treatment |
ISO |
DNA:SNP: :p.K751Q (rs13181) (human) associated with Leukemia, Myeloid, Acute;DNA:SNPs, haplotypes: :p.D312N, p.K751Q (human) |
RGD |
PMID:15339847, PMID:17197435 |
RGD:11252202, RGD:11252178 |
NCBI chr 1:80,293,574...80,307,334
Ensembl chr 1:80,293,566...80,307,344
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 |
|
NCBI chr 2:181,997,562...182,013,726
Ensembl chr 2:182,006,242...182,013,763
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr 2:113,109,949...113,415,171
Ensembl chr 2:113,112,902...113,345,577
|
|
G |
Gata4 |
GATA binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31190750 |
|
NCBI chr15:46,386,703...46,458,679
Ensembl chr15:46,386,712...46,432,965
|
|
G |
Gata6 |
GATA binding protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31190750 |
|
NCBI chr18:2,415,821...2,447,087
Ensembl chr18:2,416,552...2,446,338
|
|
G |
Gc |
GC, vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr14:20,267,023...20,302,577
Ensembl chr14:20,266,891...20,302,581
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 9:27,366,404...27,381,004
Ensembl chr 9:27,368,272...27,452,902
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 PMID:24361871 PMID:28885000 |
|
NCBI chr10:31,813,819...31,860,934
Ensembl chr10:31,813,814...31,848,379
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27474498 |
|
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18227147 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Homer1 |
homer scaffold protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24126708 |
|
NCBI chr 2:22,909,550...23,012,303
Ensembl chr 2:22,909,569...23,009,678
|
|
G |
Hp |
haptoglobin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
|
|
G |
Hpx |
hemopexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 1:170,423,558...170,431,066
Ensembl chr 1:170,423,483...170,431,073
|
|
G |
Hspb6 |
heat shock protein family B (small) member 6 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18948619 |
|
NCBI chr 1:89,008,117...89,010,256
Ensembl chr 1:89,008,117...89,010,256
|
|
G |
Htr2b |
5-hydroxytryptamine receptor 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16863450 |
|
NCBI chr 9:93,112,781...93,130,135
Ensembl chr 9:93,112,805...93,125,014
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20064577 |
|
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 |
|
NCBI chr14:87,448,716...87,453,783
Ensembl chr14:87,448,692...87,453,785
|
|
G |
IgG-2a |
gamma-2a immunoglobulin heavy chain |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
|
|
G |
Il3 |
interleukin 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8202718 |
|
NCBI chr10:39,620,535...39,622,973
Ensembl chr10:39,620,563...39,622,973
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:1720698 |
|
NCBI chr 7:42,269,784...42,351,054
Ensembl chr 7:42,269,784...42,351,054
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 3:11,414,189...11,417,534
Ensembl chr 3:11,414,186...11,417,546
|
|
G |
Ltbr |
lymphotoxin beta receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr 4:157,822,838...157,829,291
Ensembl chr 4:157,822,840...157,829,241
|
|
G |
Mocos |
molybdenum cofactor sulfurase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29935280 |
|
NCBI chr18:16,590,086...16,636,312
Ensembl chr18:16,590,197...16,636,084
|
|
G |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
|
ISO |
ClinVar Annotator: match by term: Brain pseudoatrophy, reversible, valproate-induced, susceptibility to |
ClinVar |
PMID:9243242 PMID:17101920 |
|
NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15753437 PMID:16166815 PMID:17387702 PMID:17502830 PMID:18551038 PMID:19159907 PMID:19391036 PMID:19821069 PMID:21064136 PMID:25007187 PMID:26077125 |
|
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15753437 PMID:19159907 |
|
NCBI chr17:66,210,444...66,295,014
Ensembl chr17:66,210,461...66,295,014
|
|
G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21064136 |
|
NCBI chr 1:37,743,089...37,774,485
Ensembl chr 1:37,743,147...37,774,015
|
|
G |
Mug1 |
murinoglobulin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 4:154,676,382...154,729,288
Ensembl chr 4:154,391,647...154,729,310
|
|
G |
Nat1 |
N-acetyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11505221 |
|
NCBI chr16:23,970,742...23,991,573
Ensembl chr16:23,970,743...23,991,573
|
|
G |
Nat2 |
N-acetyltransferase 2 |
susceptibility |
ISO |
DNA:polymorphism: : CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17377643 PMID:17502830, PMID:12786839 |
RGD:8552667 |
NCBI chr16:23,960,709...23,991,570
Ensembl chr16:23,961,067...23,991,570
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20605904 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29802709 |
|
NCBI chr18:31,728,373...32,704,022
Ensembl chr18:31,728,373...31,749,647
|
|
G |
Nt5c2 |
5'-nucleotidase, cytosolic II |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr 1:266,652,966...266,782,935
Ensembl chr 1:266,659,519...266,782,910
|
|
G |
Orm1 |
orosomucoid 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 5:79,179,668...79,182,820
Ensembl chr 5:79,179,417...79,182,820
|
|
G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr14:106,008,086...106,062,566
Ensembl chr14:106,008,086...106,061,641
|
|
G |
Plg |
plasminogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 1:48,521,828...48,563,895
Ensembl chr 1:48,521,772...48,563,776
|
|
G |
Plk2 |
polo-like kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12897130 |
|
NCBI chr 2:41,911,143...41,916,901
Ensembl chr 2:41,911,131...41,916,901
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19683050 |
|
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10698006 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ren |
renin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8723173 |
|
NCBI chr13:50,502,724...50,513,953
Ensembl chr13:50,502,724...50,514,151
|
|
G |
Rup2 |
urinary protein 2 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 8:41,657,662...41,661,223
Ensembl chr 8:41,657,566...41,661,238
|
|
G |
Serpina1 |
serpin family A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 6:127,610,241...127,632,265
Ensembl chr 6:127,610,243...127,632,265
|
|
G |
Shmt1 |
serine hydroxymethyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21064136 |
|
NCBI chr10:47,030,813...47,059,216
Ensembl chr10:47,031,050...47,059,216
|
|
G |
Slc19a1 |
solute carrier family 19 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21064136 |
|
NCBI chr20:12,334,675...12,354,517
Ensembl chr20:12,334,676...12,352,377
|
|
G |
Slc34a2 |
solute carrier family 34 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 |
|
NCBI chr14:60,257,211...60,276,516
Ensembl chr14:60,256,712...60,276,794
|
|
G |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 |
|
NCBI chr 8:111,495,443...111,577,320
Ensembl chr 8:111,495,331...111,577,833
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 |
|
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
|
|
G |
Tcn2 |
transcobalamin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15753437 |
|
NCBI chr14:84,173,992...84,189,299
Ensembl chr14:84,174,138...84,189,266
|
|
G |
Tf |
transferrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27474498 |
|
NCBI chr 3:142,748,673...142,752,325
Ensembl chr 3:142,748,674...142,752,325
|
|
G |
Tlr1 |
toll-like receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18466103 |
|
NCBI chr14:45,062,662...45,065,014
Ensembl chr14:45,062,662...45,081,991
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18466103 PMID:31557154 |
|
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Top1 |
DNA topoisomerase I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19931604 |
|
NCBI chr 3:156,635,688...156,717,686
Ensembl chr 3:156,642,464...156,717,686
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9369336 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Ttr |
transthyretin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chr18:15,532,963...15,542,180
Ensembl chr18:15,532,963...15,540,177
|
|
G |
Txn1 |
thioredoxin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11462148 |
|
NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
|
|
G |
Tyms |
thymidylate synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19648163 PMID:21064136 PMID:25007187 PMID:26077125 |
|
NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19931604 |
|
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068094 |
|
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
G |
Vkorc1 |
vitamin K epoxide reductase complex, subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26445138 |
|
NCBI chr 1:199,338,785...199,341,306
Ensembl chr 1:199,337,138...199,341,302
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
susceptibility |
ISO |
DNA:missense mutation:cds:p.G671V (human) |
RGD |
PMID:16330681 |
RGD:11041175 |
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Capn2 |
calpain 2 |
treatment |
IEP |
|
RGD |
PMID:25634181 |
RGD:13792617 |
NCBI chr13:100,878,649...100,928,811
Ensembl chr13:100,878,650...100,928,811
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
|
ISO |
associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human) |
RGD |
PMID:24284041 |
RGD:11252190 |
NCBI chr 1:80,293,574...80,307,334
Ensembl chr 1:80,293,566...80,307,344
|
|
|
G |
Cacng6 |
calcium voltage-gated channel auxiliary subunit gamma 6 |
susceptibility |
ISO |
DNA:SNP,haplotype:rs192808(human) |
RGD |
PMID:20860846 |
RGD:13524562 |
NCBI chr 1:64,307,684...64,322,124
Ensembl chr 1:64,305,438...64,321,241
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159, PMID:20022477 |
RGD:4145619 |
NCBI chr 8:133,026,539...133,040,999
Ensembl chr 8:133,029,625...133,040,997
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:17641958 PMID:20485159 |
|
NCBI chr X:77,671,028...77,700,491
Ensembl chr X:77,674,150...77,700,269
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:20485159, PMID:15970796 |
RGD:5144000 |
NCBI chr15:54,903,290...54,941,742
Ensembl chr15:54,905,274...54,906,203
|
|
G |
Fancc |
FA complementation group C |
|
ISO |
DNA:haplotype::rs4647416(human) |
RGD |
PMID:21670957 |
RGD:11045795 |
NCBI chr17:826,512...955,703
Ensembl chr17:833,509...955,615
|
|
G |
Il4 |
interleukin 4 |
susceptibility |
ISO |
DNA:SNPs:promoter,5'UTR,intron:multiple |
RGD |
PMID:20921925 |
RGD:11528633 |
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159 |
|
NCBI chr10:35,736,486...35,743,088
Ensembl chr10:35,737,664...35,739,625
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chr 1:227,957,363...227,965,312
Ensembl chr 1:227,957,302...227,965,386
|
|
G |
Postn |
periostin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18391768 |
|
NCBI chr 2:143,656,820...143,688,087
Ensembl chr 2:143,656,793...143,688,087
|
|
G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chr 1:226,976,455...226,995,641
Ensembl chr 1:226,993,250...226,994,849
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:15496426 PMID:16502481 |
|
NCBI chr15:19,336,029...19,349,759
Ensembl chr15:19,338,175...19,350,210
|
|
G |
Ptgir |
prostaglandin I2 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chr 1:78,833,449...78,835,832
Ensembl chr 1:78,833,157...78,837,623
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:increased expression:mast cell CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:20485159, PMID:9487340 |
RGD:5143936 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
|
RGD |
PMID:25975240 |
RGD:11074090 |
NCBI chr20:4,066,133...4,070,726
Ensembl chr20:4,066,132...4,070,721
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
|
RGD |
PMID:25975240 |
RGD:11074090 |
NCBI chr20:4,043,726...4,049,367
Ensembl chr20:4,039,413...4,049,711
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
susceptibility |
ISO |
|
RGD |
PMID:25975240 |
RGD:11074090 |
NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
|
ISO |
|
RGD |
PMID:21796142 |
RGD:5147839 |
NCBI chr20:3,995,544...4,009,587
Ensembl chr20:3,995,544...4,009,587
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:15806396 PMID:16502481 |
|
NCBI chr10:85,032,799...85,049,331
Ensembl chr10:85,032,799...85,049,331
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
susceptibility |
ISO |
DNA:polymorphism: :795T>C (human) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:20485159, PMID:15898979 |
RGD:11059537 |
NCBI chr 7:11,253,153...11,259,233
Ensembl chr 7:11,253,180...11,257,977
|
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
ClinVar |
PMID:17959182 PMID:21558275 PMID:30643255 |
|
NCBI chr10:56,953,692...56,962,145
Ensembl chr10:56,953,691...56,962,161
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
|
OMIM |
|
|
NCBI chr15:19,336,029...19,349,759
Ensembl chr15:19,338,175...19,350,210
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
OMIM ClinVar |
PMID:25741868 |
|
NCBI chr10:85,032,799...85,049,331
Ensembl chr10:85,032,799...85,049,331
|
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26145887 |
|
NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29800642 |
|
NCBI chr 3:126,335,963...126,346,771
Ensembl chr 3:126,335,863...126,346,318
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32068018 |
|
NCBI chr 2:210,522,370...210,550,546
Ensembl chr 2:210,522,375...210,550,560
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29305325 |
|
NCBI chr18:29,330,302...29,340,185
Ensembl chr18:29,329,764...29,340,403
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32068018 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Mir208a |
microRNA 208a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26454886 |
|
NCBI chr15:33,613,451...33,613,533
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human) |
RGD |
PMID:26345518 |
RGD:11533645 |
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr 5:164,796,176...164,797,538
Ensembl chr 5:164,796,185...164,797,531
|
|
G |
Nrg1 |
neuregulin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29305325 |
|
NCBI chr16:62,969,573...64,065,063
Ensembl chr16:63,837,216...64,057,434
|
|
G |
Rac1 |
Rac family small GTPase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28710503 |
|
NCBI chr12:13,090,316...13,111,841
Ensembl chr12:13,090,172...13,111,873
|
|
G |
Rarg |
retinoic acid receptor, gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26237429 |
|
NCBI chr 7:143,840,739...143,863,206
Ensembl chr 7:143,839,980...143,863,186
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 PMID:32068018 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30009776 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 4:50,152,005...50,208,935
Ensembl chr 4:50,152,452...50,200,328
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
severity |
ISO |
DNA:SNP: :rs2287616(human) |
RGD |
PMID:27293027 |
RGD:14402413 |
NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
severity susceptibility |
ISO |
DNA:SNP::2677G>T/A(rs2032582)(human) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 PMID:26134275, PMID:26134275, PMID:27296832 |
RGD:11041130, RGD:14700895 |
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27193730 |
|
NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18466103 |
|
NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-24C>T(human) |
CTD |
PMID:18381794 PMID:18466103, PMID:17241877, PMID:25196354 |
RGD:14700814, RGD:14700812 |
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Abi1 |
abl-interactor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr17:89,951,662...90,033,334
Ensembl chr17:89,951,752...90,033,328
|
|
G |
Ace |
angiotensin I converting enzyme |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25143335 |
RGD:25671447 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr14:80,313,202...80,358,115
Ensembl chr14:80,314,431...80,355,420
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
|
|
G |
Actb |
actin, beta |
|
IEP ISO |
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249, PMID:22563491 |
RGD:9587759 |
NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841
|
|
G |
Actn4 |
actinin alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:87,078,012...87,147,347
Ensembl chr 1:87,078,020...87,147,333
|
|
G |
Actr3 |
actin related protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:41,695,520...41,738,622
Ensembl chr13:41,695,183...41,738,658
|
|
G |
Ada |
adenosine deaminase |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:21161045 |
RGD:5128859 |
NCBI chr 3:160,115,840...160,139,947
Ensembl chr 3:160,115,842...160,139,947
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24646716 |
|
NCBI chr 1:212,317,510...212,332,895
Ensembl chr 1:212,317,848...212,330,349
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20709802 |
|
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adipor2 |
adiponectin receptor 2 |
severity |
IEP |
associated with obesity, LPS;mRNA:decreased expression:liver (rat) |
RGD |
PMID:23838384 |
RGD:8695926 |
NCBI chr 4:151,412,135...151,480,108
Ensembl chr 4:151,414,684...151,428,894
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29499335 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21890736 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25743375 |
|
NCBI chr X:135,304,063...135,343,062
Ensembl chr X:135,304,066...135,343,087
|
|
G |
Ak4 |
adenylate kinase 4 |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:16538043 |
RGD:2301096 |
NCBI chr 5:120,250,318...120,309,153
Ensembl chr 5:120,250,616...120,305,897
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
|
RGD |
PMID:29763686 |
RGD:27226688 |
NCBI chr 5:135,482,068...135,498,693
Ensembl chr 5:135,482,068...135,498,822
|
|
G |
Alb |
albumin |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18779383 PMID:22310181, PMID:27567545 |
RGD:14694844 |
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:26,375,866...26,425,838
Ensembl chr 7:26,375,866...26,425,108
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
severity susceptibility |
IEP ISO |
protein:increased expression:liver DNA:deletion:exon 3 (mouse) |
RGD |
PMID:21138988, PMID:30121625, PMID:24492981 |
RGD:7241599, RGD:15036810, RGD:14975148 |
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:85,580,828...85,597,497
Ensembl chr13:85,580,828...85,597,493
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16115720 |
|
NCBI chr 5:64,805,772...64,818,813
Ensembl chr 5:64,805,773...64,818,824
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18779383 |
|
NCBI chr 5:78,975,690...78,986,021
Ensembl chr 5:78,975,678...78,985,990
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
|
|
G |
Anxa6 |
annexin A6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr10:40,320,581...40,375,605
Ensembl chr10:40,320,581...40,375,605
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
|
|
G |
Apoh |
apolipoprotein H |
|
IEP ISO |
mRNA:increased expression:plasma: CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942, PMID:23288050 |
RGD:10054107 |
NCBI chr10:96,640,013...96,653,939
Ensembl chr10:96,639,924...96,653,938
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22872058 |
|
NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20935161 |
|
NCBI chr 2:196,594,178...196,651,486
Ensembl chr 2:196,594,303...196,651,179
|
|
G |
Atg5 |
autophagy related 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22491424 |
|
NCBI chr20:49,301,783...49,393,147
Ensembl chr20:49,318,308...49,393,140
|
|
G |
Atoh8 |
atonal bHLH transcription factor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:100,067,341...100,099,517
Ensembl chr 4:100,067,341...100,099,517
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:102,032,271...102,047,754
Ensembl chr 6:102,032,276...102,047,758
|
|
G |
Bad |
BCL2-associated agonist of cell death |
treatment |
IDA |
|
RGD |
PMID:25447754 |
RGD:10053709 |
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17906064 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr11:72,577,547...72,619,435
Ensembl chr11:72,578,533...72,614,176
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30685357 |
|
NCBI chr 6:129,399,468...129,429,676
Ensembl chr 6:129,399,468...129,429,676
|
|
G |
Blvrb |
biliverdin reductase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:84,256,063...84,273,726
Ensembl chr 1:84,256,159...84,274,075
|
|
G |
Bpnt1 |
3'(2'), 5'-bisphosphate nucleotidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:103,268,045...103,292,848
Ensembl chr13:103,268,068...103,292,854
|
|
G |
Brd4 |
bromodomain containing 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:14,222,101...14,303,055
Ensembl chr 7:14,222,101...14,303,055
|
|
G |
Btd |
biotinidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15469856 |
|
NCBI chr16:7,758,192...7,791,301
Ensembl chr16:7,758,996...7,791,243
|
|
G |
C3 |
complement C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
Ca3 |
carbonic anhydrase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 PMID:25231249 |
|
NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
|
|
G |
Cabp1 |
calcium binding protein 1 |
|
IEP |
protein:increased expression:liver |
RGD |
PMID:21138988 |
RGD:7241599 |
NCBI chr12:47,185,449...47,209,785
Ensembl chr12:47,179,664...47,209,784
|
|
G |
Cadps2 |
calcium dependent secretion activator 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 4:50,326,447...50,861,161
Ensembl chr 4:50,326,442...50,860,756
|
|
G |
Canx |
calnexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 5:140,559,195...140,585,494
Ensembl chr 5:140,559,206...140,585,408
|
|
G |
Casp8 |
caspase 8 |
treatment |
IEP |
|
RGD |
PMID:25447754 |
RGD:10053709 |
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Cast |
calpastatin |
|
IEP |
|
RGD |
PMID:16871587 |
RGD:5683869 |
NCBI chr 2:1,452,111...1,561,669
Ensembl chr 2:1,452,116...1,561,464
|
|
G |
Cat |
catalase |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver |
CTD |
PMID:20623750 PMID:25231249, PMID:21138988 |
RGD:7241599 |
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr11:60,645,660...60,679,249
Ensembl chr11:60,645,086...60,679,555
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750, PMID:21813474, PMID:30663942 |
RGD:14995466, RGD:14995458 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
susceptibility |
ISO |
acetaminophen |
RGD |
PMID:24770590 |
RGD:14401733 |
NCBI chr 8:133,192,398...133,215,599
Ensembl chr 8:133,197,032...133,215,614
|
|
G |
Cct3 |
chaperonin containing TCP1 subunit 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:187,669,051...187,693,610
Ensembl chr 2:187,668,796...187,693,610
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:84,667,578...84,678,730
Ensembl chr 2:84,667,633...84,678,790
|
|
G |
Cdc25b |
cell division cycle 25B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 3:123,731,539...123,741,696
Ensembl chr 3:123,731,539...123,741,339
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr14:9,396,511...9,456,964
Ensembl chr14:9,396,512...9,456,990
|
|
G |
Cela1 |
chymotrypsin like elastase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 7:142,305,337...142,318,621
Ensembl chr 7:142,305,338...142,318,620
|
|
G |
Cfap20 |
cilia and flagella associated protein 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr19:10,024,938...10,038,838
Ensembl chr19:10,024,947...10,038,784
|
|
G |
Cfh |
complement factor H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20197374 |
|
NCBI chr17:63,990,599...64,463,222
Ensembl chr17:63,990,599...63,994,169
|
|
G |
Ckb |
creatine kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 6:136,142,956...136,145,838
Ensembl chr 6:136,142,956...136,145,837
|
|
G |
Clu |
clusterin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr15:42,626,612...42,665,858
Ensembl chr15:42,640,146...42,665,857
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 7:95,054,877...95,274,073
Ensembl chr 7:95,074,236...95,273,298
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16679477 |
|
NCBI chr 9:52,023,295...52,059,221
Ensembl chr 9:52,023,295...52,059,217
|
|
G |
Comt |
catechol-O-methyltransferase |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:21138988 |
RGD:7241599 |
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
|
|
G |
Coq9 |
coenzyme Q9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr19:10,583,855...10,596,848
Ensembl chr19:10,583,857...10,596,851
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
IEP |
mRNA,protein:increased expression,increased activity:liver,plasma |
RGD |
PMID:19386599 |
RGD:7243112 |
NCBI chr15:57,290,849...57,339,762
Ensembl chr15:57,290,849...57,339,760
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 9:74,113,437...74,236,274
Ensembl chr 9:74,124,016...74,236,274
|
|
G |
Crp |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20005281 |
|
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19679878 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Ctse |
cathepsin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr13:48,426,833...48,449,493
Ensembl chr13:48,426,820...48,449,490
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16118408 |
|
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11739529 |
|
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16118408 |
|
NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28762043 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
|
ISO |
mRNA, protein:decreased expression:kidney (mouse) |
RGD |
PMID:26476181 |
RGD:25671412 |
NCBI chr 7:70,333,150...70,340,006
Ensembl chr 7:70,335,061...70,340,005
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23628428 |
|
NCBI chr 1:83,653,248...83,662,118
Ensembl chr 1:83,653,234...83,766,484
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28762043 |
|
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
|
|
G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12963435 PMID:28762043 |
|
NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:27490558 |
RGD:14700879 |
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism DNA:hypermethylation:promoter associated with Endotoxemia |
CTD |
PMID:12668988 PMID:16770646 PMID:21741958 PMID:28762043, PMID:27960551, PMID:27490558, PMID:27324775, PMID:29404441, PMID:25681370 |
RGD:14700901, RGD:14700879, RGD:14700878, RGD:14700873, RGD:14700872 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28762043 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 5:134,468,666...134,484,851
Ensembl chr 5:134,469,270...134,484,839
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25448281 |
|
NCBI chr 8:130,548,418...130,550,388
Ensembl chr 8:130,548,418...130,550,388
|
|
G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:219,563,783...219,592,651
Ensembl chr 2:219,563,783...219,592,650
|
|
G |
Ddb1 |
damage-specific DNA binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:226,657,561...226,683,356
Ensembl chr 1:226,657,561...226,683,347
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chr 1:164,113,459...164,143,818
Ensembl chr 1:164,113,459...164,143,818
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19648163 |
|
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:95,522,577...95,541,393
Ensembl chr 6:95,522,577...95,541,393
|
|
G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 8:55,062,549...55,087,832
Ensembl chr 8:55,062,551...55,087,832
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 6:64,165,913...64,170,122
Ensembl chr 6:64,165,913...64,170,151
|
|
G |
Dnajc12 |
DnaJ heat shock protein family (Hsp40) member C12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr20:26,893,139...26,913,041
Ensembl chr20:26,893,016...26,913,016
|
|
G |
Dsc2 |
desmocollin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr18:11,826,705...11,858,801
Ensembl chr18:11,826,706...11,858,754
|
|
G |
E2f1 |
E2F transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30515189 |
|
NCBI chr 3:150,062,895...150,073,721
Ensembl chr 3:150,047,826...150,073,721
|
|
G |
Echdc1 |
ethylmalonyl-CoA decarboxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:30,874,410...30,921,117
Ensembl chr 1:30,874,418...30,917,882
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:212,570,213...212,579,040
Ensembl chr 1:212,570,195...212,579,057
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:140,886,644...140,918,654
Ensembl chr 4:140,886,545...140,915,779
|
|
G |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25411909 |
|
NCBI chr12:12,749,026...12,782,078
Ensembl chr12:12,748,785...12,782,146
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr20:31,055,292...31,072,469
Ensembl chr20:31,055,789...31,072,469
|
|
G |
Endog |
endonuclease G |
|
IEP |
protein:decreased expression:mitochondrion: |
RGD |
PMID:22509279 |
RGD:9685364 |
NCBI chr 3:8,741,833...8,744,414
Ensembl chr 3:8,741,766...8,744,592
|
|
G |
Eng |
endoglin |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:21146604 |
RGD:7257529 |
NCBI chr 3:11,679,530...11,717,486
Ensembl chr 3:11,679,530...11,717,485
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 PMID:25231249 |
|
NCBI chr 5:167,288,223...167,299,610
Ensembl chr 5:167,288,223...167,299,609
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
IEP |
protein:increased activity:serum: |
RGD |
PMID:17850827 |
RGD:9685426 |
NCBI chr 7:94,479,931...94,563,086
Ensembl chr 7:94,480,396...94,563,001
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
|
|
G |
Erlec1 |
endoplasmic reticulum lectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr14:115,314,890...115,352,871
Ensembl chr14:115,314,890...115,352,562
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30538632 |
|
NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
|
|
G |
F13a1 |
coagulation factor XIII A1 chain |
|
ISO |
|
RGD |
PMID:22019897 |
RGD:11041813 |
NCBI chr17:28,504,650...28,680,015
Ensembl chr17:28,504,623...28,680,362
|
|
G |
F2rl3 |
F2R like thrombin or trypsin receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chr16:18,817,797...18,819,790
Ensembl chr16:18,814,622...18,819,833
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22407844 |
|
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
IEP |
|
RGD |
PMID:26062544, PMID:25447754 |
RGD:11341803, RGD:10053709 |
NCBI chr 1:217,746,176...217,748,581
Ensembl chr 1:217,742,929...217,748,628
|
|
G |
Fads1 |
fatty acid desaturase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:226,234,034...226,249,118
Ensembl chr 1:226,234,074...226,249,138
|
|
G |
Fads2 |
fatty acid desaturase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:225,906,582...226,152,568
Ensembl chr 1:226,114,413...226,152,524
|
|
G |
Fas |
Fas cell surface death receptor |
|
IEP |
protein:increased expression:liver (rat) |
RGD |
PMID:16831245 |
RGD:8662853 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
|
|
G |
Fcmr |
Fc fragment of IgM receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr13:47,602,701...47,617,065
Ensembl chr13:47,602,692...47,617,064
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chr 2:181,997,562...182,013,726
Ensembl chr 2:182,006,242...182,013,763
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
severity |
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:29883717 |
RGD:15045603 |
NCBI chr 1:101,595,579...101,596,822
Ensembl chr 1:101,595,579...101,596,822
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21135413 |
|
NCBI chr12:9,033,993...9,205,886
Ensembl chr12:9,034,308...9,205,905
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24973094 |
|
NCBI chr13:80,837,418...80,856,214
Ensembl chr13:80,837,420...80,862,963
|
|
G |
Ftl1 |
ferritin light chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:101,448,190...101,450,034
Ensembl chr 1:101,448,346...101,449,829
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
|
ISO |
mRNA:decreased expression:liver (mouse) |
RGD |
PMID:28189721 |
RGD:14695531 |
NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:21864513 |
RGD:10449168 |
NCBI chr X:156,274,800...156,293,935
Ensembl chr X:156,274,800...156,293,926
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
|
|
G |
Ganab |
glucosidase II alpha subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:225,096,558...225,116,384
Ensembl chr 1:225,096,598...225,116,378
|
|
G |
Gc |
GC, vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr14:20,267,023...20,302,577
Ensembl chr14:20,266,891...20,302,581
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19481141, PMID:17573345 |
RGD:10402383 |
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Gda |
guanine deaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:238,982,542...239,057,663
Ensembl chr 1:238,982,392...239,057,732
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr X:156,400,734...156,407,396
Ensembl chr X:156,400,736...156,407,404
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO IDA |
|
RGD |
PMID:22033404, PMID:15968720 |
RGD:9685722, RGD:9685727 |
NCBI chr10:14,059,347...14,061,703
Ensembl chr10:14,059,347...14,061,703
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21219404 |
|
NCBI chr 5:34,040,258...34,063,369
Ensembl chr 5:34,040,258...34,063,361
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
IEP |
|
RGD |
PMID:10934156 |
RGD:14701049 |
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:263,246,248...263,269,762
Ensembl chr 1:263,246,248...263,269,762
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:141,368,928...141,377,931
Ensembl chr 7:141,370,491...141,377,928
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression, activity:serum: |
CTD |
PMID:145039 PMID:19481104, PMID:19085960, PMID:19085960, PMID:27293452, PMID:21772750, PMID:28487901 |
RGD:14975249, RGD:14975249, RGD:14975168, RGD:14975166, RGD:14975162 |
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
|
IEP ISO |
protein:increased expression, activity:serum: |
RGD |
PMID:19085960, PMID:19085960 |
RGD:14975249, RGD:14975249 |
NCBI chr19:22,599,003...22,633,529
Ensembl chr19:22,590,881...22,632,071
|
|
G |
Grk4 |
G protein-coupled receptor kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr14:81,261,708...81,339,516
Ensembl chr14:81,265,672...81,339,526
|
|
G |
Gsn |
gelsolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
IEP ISO |
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 PMID:28069987, PMID:23554813, PMID:24154663 |
RGD:7257532, RGD:10401878 |
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 8:85,497,557...85,514,732
Ensembl chr 8:85,497,557...85,518,879
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
no_association |
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver |
CTD |
PMID:17465707 PMID:18666253, PMID:25501156, PMID:24465778, PMID:24903797, PMID:29523098, PMID:21138988 |
RGD:14700970, RGD:14700959, RGD:14700941, RGD:14700937, RGD:7241599 |
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr 2:210,778,041...210,782,807
Ensembl chr 2:210,720,704...210,782,856
|
|
G |
Gstm3 |
glutathione S-transferase mu 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25743375 |
|
NCBI chr 2:210,685,204...210,688,273
Ensembl chr 2:210,685,197...210,688,272
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:210,834,013...210,839,242
Ensembl chr 2:210,833,884...210,839,295
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25743375 |
|
NCBI chr 2:210,685,338...210,688,133
Ensembl chr 2:210,685,197...210,688,272
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:267,607,437...267,617,387
Ensembl chr 1:267,607,418...267,617,387
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 PMID:25226513 |
|
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18397238 PMID:18666253 PMID:25226513 |
|
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
H2ax |
H2A.X variant histone |
treatment |
IDA |
|
RGD |
PMID:23265463 |
RGD:8693741 |
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
|
|
G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr16:7,720,047...7,758,119
Ensembl chr16:7,714,465...7,758,189
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:27,589,840...27,628,921
Ensembl chr 6:27,589,657...27,629,175
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
|
IEP |
mRNA:increased expression:hepatocyte |
RGD |
PMID:24373749 |
RGD:11041724 |
NCBI chr 1:89,368,021...89,369,960
Ensembl chr 1:89,368,021...89,369,960
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:200,785,492...200,808,868
Ensembl chr 2:200,778,122...200,808,857
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr10:31,813,819...31,860,934
Ensembl chr10:31,813,814...31,848,379
|
|
G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr10:15,602,794...15,603,649
Ensembl chr10:15,602,794...15,603,649
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19783637, PMID:29091898 |
RGD:15090820 |
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:18227147 PMID:22688006, PMID:22886620, PMID:29091898 |
RGD:10762620, RGD:15090820 |
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hpd |
4-hydroxyphenylpyruvate dioxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 PMID:22872058 |
|
NCBI chr12:38,828,606...38,839,956
Ensembl chr12:38,828,444...38,839,969
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr X:158,196,640...158,228,815
Ensembl chr X:158,197,149...158,228,749
|
|
G |
Hpx |
hemopexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 1:170,423,558...170,431,066
Ensembl chr 1:170,423,483...170,431,073
|
|
G |
Hrh2 |
histamine receptor H 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22926047 |
|
NCBI chr17:10,912,959...10,931,389
Ensembl chr17:10,921,507...10,952,441
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
IEP |
protein:altered localization:liver (rat) |
RGD |
PMID:12376827 |
RGD:10059389 |
NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
IEP |
|
RGD |
PMID:29091898 |
RGD:15090820 |
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
|
RGD |
PMID:31121248 |
RGD:14985250 |
NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
|
|
G |
Ido2 |
indoleamine 2,3-dioxygenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32289347 |
|
NCBI chr16:72,232,852...72,291,227
Ensembl chr16:72,268,943...72,289,156
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12153990 PMID:21245496, PMID:30013034 |
RGD:14975100 |
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23639586 PMID:25226513 |
|
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
|
|
G |
Il11 |
interleukin 11 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11421492 |
|
NCBI chr 1:72,636,959...72,643,255
Ensembl chr 1:72,635,267...72,643,255
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19633216 PMID:24949944 |
|
NCBI chr 9:26,841,299...26,844,786
Ensembl chr 9:26,841,299...26,844,786
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19164858 |
|
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8218930 |
|
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
IDA IEP ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:19164858 PMID:28138970, PMID:23102243, PMID:29091898, PMID:31342809, PMID:31077717, PMID:29278859 |
RGD:7204421, RGD:15090820, RGD:15036799, RGD:14975281, RGD:13793380 |
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chr 9:46,840,646...46,881,241
Ensembl chr 9:46,840,992...46,881,264
|
|
G |
Il22 |
interleukin 22 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15122762 PMID:16212920 PMID:23375450 |
|
NCBI chr 7:61,236,037...61,240,502
Ensembl chr 7:61,236,037...61,240,502
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:21094227 PMID:21735453 PMID:22107450 |
|
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Il6 |
interleukin 6 |
treatment |
ISO IEP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7532385 PMID:15763341, PMID:29091898 |
RGD:15090820 |
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Immt |
inner membrane mitochondrial protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 4:99,753,446...99,789,921
Ensembl chr 4:99,753,500...99,792,484
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr X:156,716,469...156,726,367
Ensembl chr X:156,716,604...156,725,977
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:140,247,297...140,580,749
Ensembl chr 4:140,247,313...140,580,748
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30515189 |
|
NCBI chr16:20,485,028...20,486,707
Ensembl chr16:20,485,029...20,486,707
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
ISO |
|
RGD |
PMID:18417483 |
RGD:6893370 |
NCBI chr 8:22,250,518...22,259,868
Ensembl chr 8:22,250,518...22,259,779
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12594235 |
|
NCBI chr 7:42,269,784...42,351,054
Ensembl chr 7:42,269,784...42,351,054
|
|
G |
Kng2 |
kininogen 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20362651 PMID:30685357 |
|
NCBI chr11:81,509,185...81,516,759
|
|
G |
Krt18 |
keratin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (mouse) |
CTD |
PMID:19783637, PMID:17340120 |
RGD:18337498 |
NCBI chr 7:143,629,455...143,633,131
Ensembl chr 7:143,629,455...143,633,131
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:143,596,511...143,603,745
Ensembl chr 7:143,596,511...143,603,803
|
|
G |
Lap3 |
leucine aminopeptidase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr14:70,102,813...70,121,797
Ensembl chr14:70,102,814...70,121,797
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 3:154,786,232...154,812,910
Ensembl chr 3:154,786,215...154,813,464
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20362651 PMID:20623750 |
|
NCBI chr 3:11,414,189...11,417,534
Ensembl chr 3:11,414,186...11,417,546
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22461450 |
|
NCBI chr15:24,153,602...24,165,537
Ensembl chr15:24,141,651...24,165,537
|
|
G |
LOC100364500 |
RT1 class I, locus CE11-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21570397 PMID:28043905 |
|
NCBI chr20:2,704,153...2,707,111
Ensembl chr20:2,704,148...2,707,120
|
|
G |
Lpl |
lipoprotein lipase |
treatment |
IEP |
|
RGD |
PMID:27071702 |
RGD:13794380 |
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
|
|
G |
Lrat |
lecithin retinol acyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:181,896,304...181,905,366
Ensembl chr 2:181,896,305...181,905,300
|
|
G |
Ltb4r |
leukotriene B4 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28487374 |
|
NCBI chr15:34,449,299...34,453,352
Ensembl chr15:34,452,116...34,453,171
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16141546 |
|
NCBI chr 8:119,290,416...119,313,261
Ensembl chr 8:119,290,416...119,313,261
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr19:53,635,449...53,643,970
Ensembl chr19:53,629,779...53,646,058
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18700144 |
|
NCBI chr 1:15,412,603...15,613,752
Ensembl chr 1:15,412,603...15,613,746
|
|
G |
Mat1a |
methionine adenosyltransferase 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr16:18,690,649...18,709,135
Ensembl chr16:18,690,246...18,709,133
|
|
G |
Mccc1 |
methylcrotonoyl-CoA carboxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:122,550,777...122,690,540
Ensembl chr 2:122,550,775...122,690,617
|
|
G |
Mdh1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr14:106,378,349...106,393,642
Ensembl chr14:106,378,942...106,393,670
|
|
G |
Me1 |
malic enzyme 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 8:94,256,830...94,368,834
Ensembl chr 8:94,256,839...94,368,834
|
|
G |
Med1 |
mediator complex subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16109766 |
|
NCBI chr10:86,101,560...86,145,271
Ensembl chr10:86,103,600...86,144,880
|
|
G |
Mir100 |
microRNA 100 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 8:45,746,948...45,747,027
Ensembl chr 8:45,746,948...45,747,027
|
|
G |
Mir103a1 |
microRNA 103a-1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr10:20,606,715...20,606,800
Ensembl chr10:20,606,715...20,606,800
|
|
G |
Mir106b |
microRNA 106b |
|
IEP IDA |
miRNA:decreased expression:liver (rat) DNA:hypermethylation:promoter |
RGD |
PMID:29554950, PMID:29554950 |
RGD:15042854, RGD:15042854 |
NCBI chr12:19,307,752...19,307,833
Ensembl chr12:19,307,752...19,307,833
|
|
G |
Mir107 |
microRNA 107 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25359176 PMID:28545106 |
|
NCBI chr 1:253,128,250...253,128,336
Ensembl chr 1:253,128,250...253,128,336
|
|
G |
Mir10a |
microRNA 10a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr10:84,165,950...84,166,059
Ensembl chr10:84,165,950...84,166,059
|
|
G |
Mir10b |
microRNA 10b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 3:61,647,978...61,648,086
Ensembl chr 3:61,647,978...61,648,086
|
|
G |
Mir122 |
microRNA 122 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22045675 PMID:22363424 PMID:25359176 PMID:25527335 PMID:26489516 PMID:28545106 PMID:28844483 |
|
NCBI chr18:60,755,285...60,755,369
|
|
G |
Mir1249 |
microRNA 1249 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 7:125,861,192...125,861,311
Ensembl chr 7:125,861,192...125,861,311
|
|
G |
Mir125b1 |
microRNA 125b-1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 8:45,798,260...45,798,346
Ensembl chr 8:45,798,260...45,798,346
|
|
G |
Mir125b2 |
microRNA 125b-2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr11:16,097,346...16,097,433
|
|
G |
Mir1306 |
microRNA 1306 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr11:86,857,633...86,857,705
Ensembl chr11:86,857,632...86,857,711
|
|
G |
Mir130a |
microRNA 130a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25359176 PMID:28545106 |
|
NCBI chr 3:72,141,037...72,141,124
Ensembl chr 3:72,141,037...72,141,124
|
|
G |
Mir130b |
microRNA 130b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr11:88,129,773...88,129,854
Ensembl chr11:88,129,773...88,129,854
|
|
G |
Mir132 |
microRNA 132 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr10:62,014,995...62,015,095
Ensembl chr10:62,014,995...62,015,095
|
|
G |
Mir141 |
microRNA 141 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 PMID:28545106 |
|
NCBI chr 4:157,236,346...157,236,439
Ensembl chr 4:157,236,346...157,236,439
|
|
G |
Mir142 |
microRNA 142 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:75,050,839...75,050,925
Ensembl chr10:75,050,832...75,050,942
|
|
G |
Mir143 |
microRNA 143 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30125006 |
|
NCBI chr18:56,971,273...56,971,377
Ensembl chr18:56,971,273...56,971,377
|
|
G |
Mir148a |
microRNA 148a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25359176 PMID:28545106 |
|
NCBI chr 4:81,013,269...81,013,365
Ensembl chr 4:81,013,269...81,013,365
|
|
G |
Mir150 |
microRNA 150 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 1:101,115,974...101,116,058
Ensembl chr 1:101,115,974...101,116,058
|
|
G |
Mir151b |
microRNA 151b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 7:114,485,547...114,485,666
Ensembl chr 7:114,485,547...114,485,666
|
|
G |
Mir152 |
microRNA 152 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:84,719,319...84,719,403
Ensembl chr10:84,719,319...84,719,403
|
|
G |
Mir155 |
microRNA 155 |
treatment |
ISO |
|
RGD |
PMID:29420849, PMID:26867493, PMID:27673475 |
RGD:21409750, RGD:25671474, RGD:25671463 |
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Mir17 |
microRNA 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr15:100,179,879...100,179,962
Ensembl chr15:100,179,879...100,179,962
|
|
G |
Mir181c |
microRNA 181c |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr19:25,290,211...25,290,316
Ensembl chr19:25,290,211...25,290,316
|
|
G |
Mir188 |
microRNA 188 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr X:16,110,270...16,110,349
Ensembl chr X:16,110,270...16,110,349
|
|
G |
Mir18a |
microRNA 18a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr15:100,180,015...100,180,110
Ensembl chr15:100,180,015...100,180,110
|
|
G |
Mir191 |
microRNA 191 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 8:117,354,364...117,354,454
|
|
G |
Mir192 |
microRNA 192 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22045675 PMID:25359176 PMID:28483554 PMID:28545106 |
|
NCBI chr 1:221,634,971...221,635,080
Ensembl chr 1:221,634,971...221,635,080
|
|
G |
Mir193a |
microRNA 193a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:67,065,885...67,065,996
Ensembl chr10:67,065,885...67,065,996
|
|
G |
Mir193b |
microRNA 193b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr14:30,331,049...30,331,131
Ensembl chr14:30,331,049...30,331,131
|
|
G |
Mir194-1 |
microRNA 194-1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28844483 |
|
NCBI chr13:103,250,576...103,250,658
Ensembl chr13:103,250,576...103,250,658
|
|
G |
Mir19a |
microRNA 19a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr15:100,180,162...100,180,243
Ensembl chr15:100,180,162...100,180,243
|
|
G |
Mir1b |
microRNA 1b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30125006 |
|
NCBI chr 3:175,769,716...175,769,800
Ensembl chr 3:175,769,716...175,769,800
|
|
G |
Mir200c |
microRNA 200c |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 4:157,236,786...157,236,854
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
|
|
G |
Mir210 |
microRNA 210 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 1:214,208,355...214,208,464
|
|
G |
Mir217 |
microRNA 217 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr14:113,119,529...113,119,633
Ensembl chr14:113,119,529...113,119,633
|
|
G |
Mir22 |
microRNA 22 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25359176 PMID:28545106 |
|
NCBI chr10:62,299,592...62,299,686
Ensembl chr10:62,299,592...62,299,686
|
|
G |
Mir221 |
microRNA 221 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr X:3,684,480...3,684,588
Ensembl chr X:3,684,480...3,684,588
|
|
G |
Mir222 |
microRNA 222 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr X:3,683,919...3,684,021
Ensembl chr X:3,683,919...3,684,021
|
|
G |
Mir223 |
microRNA 223 |
|
ISO |
RNA:increased expression:serum,liver |
RGD |
PMID:28646120 |
RGD:21408574 |
NCBI chr X:65,367,812...65,367,921
Ensembl chr X:65,367,812...65,367,921
|
|
G |
Mir23a |
microRNA 23a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr19:25,318,582...25,318,656
Ensembl chr19:25,318,582...25,318,656
|
|
G |
Mir23b |
microRNA 23b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr17:823,222...823,318
Ensembl chr17:823,222...823,318
|
|
G |
Mir27b |
microRNA 27b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25359176 PMID:28545106 |
|
NCBI chr17:823,461...823,557
Ensembl chr17:823,461...823,557
|
|
G |
Mir29b2 |
microRNA 29b-2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr13:113,782,057...113,782,137
Ensembl chr13:113,782,057...113,782,140
|
|
G |
Mir301a |
microRNA 301a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:74,417,746...74,417,845
Ensembl chr10:74,417,746...74,417,845
|
|
G |
Mir30a |
microRNA 30a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 PMID:25359176 PMID:28545106 |
|
NCBI chr 9:29,542,635...29,542,705
Ensembl chr 9:29,542,635...29,542,705
|
|
G |
Mir30b |
microRNA 30b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 7:109,282,662...109,282,747
Ensembl chr 7:109,282,658...109,282,752
|
|
G |
Mir30c1 |
microRNA 30c-1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 5:139,699,877...139,699,965
Ensembl chr 5:139,699,877...139,699,965
|
|
G |
Mir320a |
microRNA 320a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 PMID:30125006 |
|
NCBI chr15:52,134,276...52,134,357
Ensembl chr15:52,134,276...52,134,357
|
|
G |
Mir328 |
microRNA 328 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr19:37,263,199...37,263,282
Ensembl chr19:37,263,199...37,263,282
|
|
G |
Mir337 |
microRNA 337 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 6:133,705,920...133,706,016
Ensembl chr 6:133,705,920...133,706,016
|
|
G |
Mir342 |
microRNA 342 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 6:132,561,169...132,561,267
Ensembl chr 6:132,561,169...132,561,267
|
|
G |
Mir345 |
microRNA 345 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 6:132,748,968...132,749,063
Ensembl chr 6:132,748,968...132,749,063
|
|
G |
Mir34a |
microRNA 34a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 5:167,092,491...167,092,592
Ensembl chr 5:167,092,491...167,092,592
|
|
G |
Mir34c |
microRNA 34c |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 8:55,492,024...55,492,100
Ensembl chr 8:55,492,024...55,492,100
|
|
G |
Mir3545 |
microRNA 3545 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:32659284 |
|
NCBI chr 6:136,704,947...136,705,061
Ensembl chr 6:136,704,947...136,705,061
|
|
G |
Mir361 |
microRNA 361 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr X:84,708,911...84,708,980
Ensembl chr X:84,708,911...84,708,980
|
|
G |
Mir410 |
microRNA 410 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr 6:133,893,997...133,894,072
Ensembl chr 6:133,893,993...133,894,073
|
|
G |
Mir423 |
microRNA 423 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:63,098,366...63,098,444
Ensembl chr10:63,098,360...63,098,453
|
|
G |
Mir455 |
microRNA 455 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 5:79,097,208...79,097,285
Ensembl chr 5:79,097,208...79,097,285
|
|
G |
Mir484 |
microRNA 484 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:27,845...27,921
Ensembl chr10:27,845...27,921
|
|
G |
Mir497 |
microRNA 497 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr10:56,844,977...56,845,045
Ensembl chr10:56,844,977...56,845,045
|
|
G |
Mir499a |
microRNA 499a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 3:151,138,862...151,138,926
Ensembl chr 3:151,138,862...151,138,926
|
|
G |
Mir503 |
microRNA 503 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr X:158,148,476...158,148,546
Ensembl chr X:158,148,476...158,148,546
|
|
G |
Mir532 |
microRNA 532 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr X:16,109,870...16,109,948
Ensembl chr X:16,109,870...16,109,948
|
|
G |
Mir592 |
microRNA 592 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 PMID:28545106 |
|
NCBI chr 4:55,182,370...55,182,465
Ensembl chr 4:55,182,370...55,182,465
|
|
G |
Mir764 |
microRNA 764 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363424 |
|
NCBI chr X:118,123,251...118,123,358
Ensembl chr X:118,123,251...118,123,358
|
|
G |
Mir877 |
microRNA 877 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27713024 |
|
NCBI chr20:3,318,872...3,318,956
Ensembl chr20:3,318,872...3,318,956
|
|
G |
Mir93 |
microRNA 93 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr12:19,307,543...19,307,629
Ensembl chr12:19,307,543...19,307,629
|
|
G |
Mir99a |
microRNA 99a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr11:16,052,153...16,052,233
Ensembl chr11:16,052,153...16,052,233
|
|
G |
Mirlet7b |
microRNA let-7b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 PMID:30125006 |
|
NCBI chr 7:126,590,627...126,590,711
Ensembl chr 7:126,590,627...126,590,711
|
|
G |
Mirlet7c1 |
microRNA let-7c-1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr11:16,052,873...16,052,966
Ensembl chr11:16,052,868...16,052,975
|
|
G |
Mirlet7d |
microRNA let-7d |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr17:16,419,980...16,420,077
Ensembl chr17:16,419,980...16,420,077
|
|
G |
Mirlet7g |
microRNA let-7g |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 8:114,874,457...114,874,544
Ensembl chr 8:114,874,454...114,874,550
|
|
G |
Mirlet7i |
microRNA let-7i |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28545106 |
|
NCBI chr 7:66,802,731...66,802,815
Ensembl chr 7:66,802,732...66,802,821
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763341 |
|
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22507835 |
|
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Mst1 |
macrophage stimulating 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 8:116,857,716...116,862,286
Ensembl chr 8:116,857,684...116,862,423
|
|
G |
Mst1r |
macrophage stimulating 1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22575169 |
|
NCBI chr 8:116,686,601...116,700,132
Ensembl chr 8:116,686,601...116,700,132
|
|
G |
Mt-nd6 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 |
|
IEP |
mRNA:decreased expression:blood |
RGD |
PMID:20130021 |
RGD:8657129 |
NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human) |
CTD |
PMID:18551038 PMID:19648163, PMID:30545275 |
RGD:14696733 |
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
|
|
G |
Mtpn |
myotrophin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 4:63,012,009...63,039,422
Ensembl chr 4:63,012,011...63,039,422
|
|
G |
Mug1 |
murinoglobulin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 4:154,676,382...154,729,288
Ensembl chr 4:154,391,647...154,729,310
|
|
G |
Nat2 |
N-acetyltransferase 2 |
treatment |
ISO |
associated with Tuberculosis;DNA:haplotype: : CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11915035 PMID:16799928 PMID:17950035 PMID:25693865, PMID:18023090 |
RGD:8552665 |
NCBI chr16:23,960,709...23,991,570
Ensembl chr16:23,961,067...23,991,570
|
|
G |
Ndufs3 |
NADH:ubiquinone oxidoreductase core subunit S3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 3:79,721,686...79,728,863
Ensembl chr 3:79,721,694...79,728,879
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
treatment |
ISO IEP |
induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620) CTD Direct Evidence: therapeutic |
CTD |
PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:30215777, PMID:18417483, PMID:31889292, PMID:31927046, PMID:32066295, PMID:31972209, PMID:29091898 |
RGD:6893370, RGD:21201308, RGD:21201305, RGD:21201283, RGD:21201280, RGD:15090820 |
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
treatment susceptibility |
IEP ISO |
associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human) |
RGD |
PMID:29091898, PMID:31490979 |
RGD:15090820, RGD:40902984 |
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
|
|
G |
Nfxl1 |
nuclear transcription factor, X-box binding-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr14:38,192,462...38,233,852
Ensembl chr14:38,192,446...38,233,852
|
|
G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr10:81,648,216...81,653,717
Ensembl chr10:81,648,216...81,653,717
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30394310 |
|
NCBI chr 3:3,905,562...3,951,015
Ensembl chr 3:3,905,453...3,951,025
|
|
G |
Nox4 |
NADPH oxidase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:150,796,359...150,976,186
Ensembl chr 1:150,797,084...150,976,194
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IDA IEP ISO |
|
RGD |
PMID:28522909, PMID:29091898, PMID:28472605 |
RGD:13439737, RGD:15090820, RGD:13439739 |
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29943110 |
|
NCBI chr 5:151,776,004...151,779,319
Ensembl chr 5:151,776,004...151,779,319
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
treatment |
ISO |
|
RGD |
PMID:24497272 |
RGD:10448995 |
NCBI chr10:86,683,875...86,690,815
Ensembl chr10:86,683,875...86,690,815
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17256725 |
|
NCBI chr 3:80,004,130...80,014,197
Ensembl chr 3:80,004,130...80,012,750
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
treatment severity |
ISO IEP |
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver (rat) protein:decreased expression:liver (rat) |
CTD |
PMID:12875239, PMID:29091898, PMID:28827769, PMID:30068870, PMID:22711662, PMID:20573685 |
RGD:15090820, RGD:15045609, RGD:15042870, RGD:14701036, RGD:14701035 |
NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human) |
CTD |
PMID:19797606 PMID:28058446, PMID:31490979 |
RGD:40902984 |
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:14742670 PMID:25656644 PMID:28058446 |
|
NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
|
|
G |
Nr2f2 |
nuclear receptor subfamily 2, group F, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:131,447,671...131,465,749
Ensembl chr 1:131,448,447...131,460,473
|
|
G |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29515023 |
|
NCBI chr13:53,750,470...53,870,288
Ensembl chr13:53,750,473...53,870,428
|
|
G |
Nrep |
neuronal regeneration related protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr18:26,183,753...26,212,796
Ensembl chr18:26,185,259...26,211,445
|
|
G |
Obp3 |
alpha-2u globulin PGCL4 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 5:77,313,357...77,316,875
|
|
G |
Ociad1 |
OCIA domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr14:37,458,023...37,475,485
Ensembl chr14:37,458,029...37,475,418
|
|
G |
Ogdh |
oxoglutarate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr14:86,414,924...86,481,903
Ensembl chr14:86,414,949...86,613,327
|
|
G |
Olr59 |
olfactory receptor 59 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:167,906,030...167,940,688
Ensembl chr 1:167,906,061...167,911,961
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr10:109,736,459...109,748,070
Ensembl chr10:109,736,458...109,747,987
|
|
G |
Pah |
phenylalanine hydroxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:28,066,639...28,129,772
Ensembl chr 7:28,066,635...28,129,769
|
|
G |
Pan2 |
poly(A) specific ribonuclease subunit PAN2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 7:2,717,021...2,736,541
Ensembl chr 7:2,718,700...2,736,157
|
|
G |
Panx1 |
Pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chr 8:13,567,185...13,606,040
Ensembl chr 8:13,566,739...13,606,040
|
|
G |
Park7 |
Parkinsonism associated deglycase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 5:167,982,438...168,004,724
Ensembl chr 5:167,982,439...168,004,724
|
|
G |
Pc |
pyruvate carboxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:219,759,157...219,859,854
Ensembl chr 1:219,759,183...219,859,848
|
|
G |
Pcolce |
procollagen C-endopeptidase enhancer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr12:22,153,995...22,160,311
Ensembl chr12:22,153,983...22,160,337
|
|
G |
Pcyt1a |
phosphate cytidylyltransferase 1, choline, alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr11:71,547,865...71,592,037
Ensembl chr11:71,548,222...71,591,502
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:21182459 PMID:31809757 |
|
NCBI chr 4:30,546,772...30,556,774
Ensembl chr 4:30,546,664...30,556,814
|
|
G |
Pdlim5 |
PDZ and LIM domain 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:247,815,214...247,989,198
Ensembl chr 2:247,818,243...247,988,462
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:141,474,189...141,481,270
Ensembl chr 1:141,474,180...141,481,315
|
|
G |
Pgm1 |
phosphoglucomutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 5:118,743,632...118,803,055
Ensembl chr 5:118,743,632...118,803,055
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22507835 |
|
NCBI chr16:74,098,263...74,122,897
Ensembl chr16:74,098,260...74,122,889
|
|
G |
Plg |
plasminogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22507835 |
|
NCBI chr 1:48,521,828...48,563,895
Ensembl chr 1:48,521,772...48,563,776
|
|
G |
Pls3 |
plastin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr X:119,030,311...119,124,268
Ensembl chr X:119,030,419...119,124,250
|
|
G |
Pnp |
purine nucleoside phosphorylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr15:27,875,883...27,883,566
Ensembl chr15:27,875,911...27,883,350
|
|
G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 5:48,501,472...48,504,511
Ensembl chr 5:48,501,472...48,504,511
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
susceptibility no_association |
ISO IAGP |
CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human) DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human) |
CTD |
PMID:18208989 PMID:20138553, PMID:25065347, PMID:30255931 |
RGD:15039302, RGD:15039297 |
NCBI chr 1:141,172,117...141,188,893
Ensembl chr 1:141,172,531...141,188,031
|
|
G |
Polr2g |
RNA polymerase II subunit G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 1:224,991,250...224,998,355
Ensembl chr 1:224,991,222...224,994,653
|
|
G |
Pon1 |
paraoxonase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 4:30,249,749...30,276,297
Ensembl chr 4:30,249,742...30,276,372
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
LPS-induced acute liver damage CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24385052, PMID:21262334 |
RGD:5509941 |
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
mRNA, protein:decreased expression:liver |
RGD |
PMID:26599535 |
RGD:11554658 |
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Pptc7 |
protein phosphatase targeting COQ7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr12:39,731,107...39,769,480
Ensembl chr12:39,731,121...39,769,480
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
treatment |
IEP |
|
RGD |
PMID:29091898 |
RGD:15090820 |
NCBI chr 2:54,857,688...54,893,404
Ensembl chr 2:54,857,688...54,893,404
|
|
G |
Prkcd |
protein kinase C, delta |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30393195 |
|
NCBI chr16:6,655,131...6,675,746
Ensembl chr16:6,655,120...6,675,746
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224054 |
|
NCBI chr11:89,293,547...89,510,948
Ensembl chr11:89,293,696...89,510,871
|
|
G |
Ptf1a |
pancreas associated transcription factor 1a |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21182459 |
|
NCBI chr17:86,199,623...86,201,477
Ensembl chr17:86,199,623...86,201,477
|
|
G |
Ptges2 |
prostaglandin E synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31444509 |
|
NCBI chr 3:11,424,195...11,431,379
Ensembl chr 3:11,424,099...11,431,402
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
treatment |
ISO IEP |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11743745, PMID:29091898 |
RGD:15090820 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Pum1 |
pumilio RNA-binding family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 5:148,781,239...148,911,776
Ensembl chr 5:148,781,222...148,911,803
|
|
G |
Pygl |
glycogen phosphorylase L |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat) |
CTD |
PMID:25231249, PMID:25336395 |
RGD:21079733 |
NCBI chr 6:92,597,759...92,643,734
Ensembl chr 6:92,597,706...92,643,847
|
|
G |
Rasa1 |
RAS p21 protein activator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 2:13,617,021...13,696,531
Ensembl chr 2:13,616,822...13,696,426
|
|
G |
Rbp1 |
retinol binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 8:106,449,321...106,470,842
Ensembl chr 8:106,449,321...106,470,842
|
|
G |
Rdh13 |
retinol dehydrogenase 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27865848 |
|
NCBI chr 1:72,956,017...72,983,811
Ensembl chr 1:72,956,026...72,984,350
|
|
G |
Reep5 |
receptor accessory protein 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr18:27,128,462...27,159,693
Ensembl chr18:27,128,464...27,159,693
|
|
G |
Rgn |
regucalcin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr X:1,833,484...1,848,904
Ensembl chr X:1,833,492...1,848,904
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26769846 |
|
NCBI chr15:34,470,796...34,479,741
Ensembl chr15:34,470,796...34,479,741
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
DNA:polymorphism: :HLA-DQA1*0102(human) associated with tuberculosis;DNA:polymorphism: :HLA-DQA1*0102(human) |
RGD |
PMID:20639878, PMID:12359646 |
RGD:14398844, RGD:14401573 |
NCBI chr20:4,066,133...4,070,726
Ensembl chr20:4,066,132...4,070,721
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :HLA-DQB1*05(human) DNA:polymorphism, haplotype |
CTD |
PMID:21570397, PMID:25250564, PMID:26959717 |
RGD:36174016, RGD:11573514 |
NCBI chr20:4,043,726...4,049,367
Ensembl chr20:4,039,413...4,049,711
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21570397 |
|
NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190
|
|
G |
S100a11 |
S100 calcium binding protein A11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 2:193,863,185...193,868,646
Ensembl chr 2:193,866,951...193,868,502
|
|
G |
Selenbp1 |
selenium binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr 2:196,105,592...196,146,474
Ensembl chr 2:196,105,569...196,113,149
|
|
G |
Senp2 |
SUMO specific peptidase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29535048 |
|
NCBI chr11:82,627,973...82,664,702
Ensembl chr11:82,630,436...82,664,630
|
|
G |
Serpina1 |
serpin family A member 1 |
susceptibility |
IEP ISO |
protein:decreased expression:plasma DNA:missense mutation:cds:p.E264V(human) |
RGD |
PMID:11140575, PMID:20170533 |
RGD:1643168, RGD:14695048 |
NCBI chr 6:127,610,241...127,632,265
Ensembl chr 6:127,610,243...127,632,265
|
|
G |
Serpina6 |
serpin family A member 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:127,523,948...127,534,178
Ensembl chr 6:127,523,906...127,534,247
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human) |
RGD |
PMID:23183238 |
RGD:14696750 |
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Serping1 |
serpin family G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 3:72,161,230...72,171,109
Ensembl chr 3:72,161,189...72,171,078
|
|
G |
Sesn2 |
sestrin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28209544 |
|
NCBI chr 5:150,684,891...150,703,846
Ensembl chr 5:150,684,133...150,704,117
|
|
G |
Sgf29 |
SAGA complex associated factor 29 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:198,066,974...198,100,494
Ensembl chr 1:198,067,066...198,100,493
|
|
G |
Shc1 |
SHC adaptor protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 PMID:32659284 |
|
NCBI chr 2:188,745,503...188,757,066
Ensembl chr 2:188,745,503...188,757,066
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
|
IEP |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:28827769 |
RGD:15045609 |
NCBI chr 6:104,617,730...104,631,355
Ensembl chr 6:104,617,730...104,631,355
|
|
G |
Slc10a7 |
solute carrier family 10, member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr19:32,857,984...33,081,359
Ensembl chr19:32,855,343...33,080,998
|
|
G |
Slc13a4 |
solute carrier family 13 member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:62,796,732...62,841,053
Ensembl chr 4:62,797,677...62,840,357
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
|
|
G |
Slc25a29 |
solute carrier family 25 member 29 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 6:132,736,964...132,747,912
Ensembl chr 6:132,735,883...132,747,828
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chr 3:160,799,979...160,802,228
Ensembl chr 3:160,799,981...160,802,433
|
|
G |
Snx18 |
sorting nexin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chr 2:45,454,782...45,480,798
Ensembl chr 2:45,454,782...45,480,798
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 PMID:27349771 |
|
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Sod2 |
superoxide dismutase 2 |
treatment severity susceptibility |
ISO IMP |
CTD Direct Evidence: marker/mechanism associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human) DNA:SNP:cds:p.Val16Ala(human) |
CTD |
PMID:25226513, PMID:27019981, PMID:19647030, PMID:19332662, PMID:20578157 |
RGD:11060605, RGD:26923961, RGD:26923959, RGD:26923957 |
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Sod3 |
superoxide dismutase 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11529661 |
|
NCBI chr14:60,958,583...60,971,143
Ensembl chr14:60,958,592...60,964,324
|
|
G |
Sord |
sorbitol dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12763371 |
|
NCBI chr 3:114,176,127...114,207,368
Ensembl chr 3:114,176,309...114,207,366
|
|
G |
Sorl1 |
sortilin related receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 8:46,228,077...46,287,171
|
|
G |
Spin2a |
spindlin family, member 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr X:17,962,905...17,964,888
Ensembl chr X:17,962,909...17,964,888
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr14:6,673,686...6,679,965
Ensembl chr14:6,673,686...6,679,901
|
|
G |
Srp72 |
signal recognition particle 72 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr14:33,447,583...33,453,788
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
severity |
ISO |
protein:increased phosphorylation:liver, inflammatory cell (mouse) mRNA:increased expression:liver, macrophage (mouse) |
RGD |
PMID:24731448, PMID:23876342 |
RGD:25671417, RGD:25671422 |
NCBI chr 9:54,340,649...54,457,753
Ensembl chr 9:54,287,541...54,484,533
|
|
G |
Sult1c3 |
sulfotransferase family 1C member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 9:4,931,038...4,978,847
Ensembl chr 9:4,930,818...4,978,892
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr14:22,070,861...22,089,264
Ensembl chr14:22,072,024...22,089,248
|
|
G |
Sult2b1 |
sulfotransferase family 2B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27052460 |
|
NCBI chr 1:101,712,254...101,774,683
Ensembl chr 1:101,710,959...101,773,508
|
|
G |
Suox |
sulfite oxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:3,098,228...3,102,179
Ensembl chr 7:3,098,245...3,102,142
|
|
G |
Tagln2 |
transgelin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr13:90,807,196...90,814,119
Ensembl chr13:90,807,199...90,814,119
|
|
G |
Taldo1 |
transaldolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19436114 |
|
NCBI chr 1:214,375,555...214,385,886
Ensembl chr 1:214,375,515...214,385,885
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22206755 |
|
NCBI chr 7:11,253,153...11,259,233
Ensembl chr 7:11,253,180...11,257,977
|
|
G |
Tctn1 |
tectonic family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chr12:39,790,948...39,828,215
Ensembl chr12:39,790,965...39,824,064
|
|
G |
Tf |
transferrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
treatment |
ISO |
|
RGD |
PMID:27516150 |
RGD:14995464 |
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28560358 |
|
NCBI chr 5:63,056,071...63,119,635
Ensembl chr 5:63,050,758...63,119,635
|
|
G |
Tlr4 |
toll-like receptor 4 |
disease_progression |
IEP |
|
RGD |
PMID:17504260 |
RGD:14697733 |
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
|
|
G |
Tlr5 |
toll-like receptor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30508503 |
|
NCBI chr13:101,364,784...101,385,764
Ensembl chr13:101,381,510...101,385,764
|
|
G |
Tlr9 |
toll-like receptor 9 |
severity treatment |
ISO |
protein:increased expression: blood, neutrophil (human) |
RGD |
PMID:26457748, PMID:19164858, PMID:23509352 |
RGD:18337465, RGD:18337476, RGD:18337473 |
NCBI chr 8:114,916,122...114,920,171
Ensembl chr 8:114,916,122...114,920,171
|
|
G |
Tmed7 |
transmembrane p24 trafficking protein 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr18:40,579,182...40,586,260
Ensembl chr18:40,579,182...40,586,260
|
|
G |
Tmem117 |
transmembrane protein 117 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 7:135,880,294...136,403,012
Ensembl chr 7:136,182,224...136,403,012
|
|
G |
Tmem164 |
transmembrane protein 164 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr X:113,947,355...114,110,064
Ensembl chr X:113,948,654...114,110,062
|
|
G |
Tmem38b |
transmembrane protein 38B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 5:70,639,156...70,675,055
Ensembl chr 5:70,639,156...70,675,054
|
|
G |
Tnf |
tumor necrosis factor |
treatment severity |
IDA IEP IMP ISO |
protein:increased expression:serum (rat) CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:7532385 PMID:9696492 PMID:17709330 PMID:19638433 PMID:20623750 PMID:21984482, PMID:15830285, PMID:29091898, PMID:31342809, PMID:14686721, PMID:10801288, PMID:10801287, PMID:9309314, PMID:17070847, PMID:31077717, PMID:11124822 |
RGD:10450531, RGD:15090820, RGD:15036799, RGD:14995485, RGD:14995437, RGD:14995435, RGD:14995432, RGD:14995429, RGD:14975281, RGD:14696804 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
ISO |
|
RGD |
PMID:24569808 |
RGD:9999438 |
NCBI chr20:11,434,062...11,482,880
Ensembl chr20:11,436,267...11,482,051
|
|
G |
Ttr |
transthyretin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chr18:15,532,963...15,542,180
Ensembl chr18:15,532,963...15,540,177
|
|
G |
Tuba1a |
tubulin, alpha 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 7:140,637,287...140,640,953
Ensembl chr 7:140,637,287...140,640,953
|
|
G |
Tubb4b |
tubulin, beta 4B class IVb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 3:2,441,585...2,444,369
Ensembl chr 3:2,441,733...2,444,281
|
|
G |
Uba5 |
ubiquitin-like modifier activating enzyme 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chr 8:112,578,607...112,594,192
Ensembl chr 8:112,578,590...112,594,261
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
susceptibility |
ISO |
DNA:SNP:exon (rs4148323)(human) |
RGD |
PMID:28900877 |
RGD:14694824 |
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chr 9:95,161,157...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
G |
Unc93b1 |
unc-93 homolog B1, TLR signaling regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:219,172,987...219,183,941
Ensembl chr 1:219,144,205...219,183,963
|
|
G |
Usp5 |
ubiquitin specific peptidase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 4:157,332,735...157,347,803
Ensembl chr 4:157,332,740...157,347,803
|
|
G |
Ust5r |
integral membrane transport protein UST5r |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 1:224,457,895...224,533,994
Ensembl chr 1:224,457,900...224,533,219
|
|
G |
Vegfa |
vascular endothelial growth factor A |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249, PMID:17784864 |
RGD:15003197 |
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr17:80,882,715...80,891,200
Ensembl chr17:80,882,666...80,891,212
|
|
G |
Vwf |
von Willebrand factor |
|
IEP ISO |
protein:increased expression:liver: CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28527913, PMID:7531171 |
RGD:11079232 |
NCBI chr 4:158,085,059...158,219,525
Ensembl chr 4:158,088,505...158,219,523
|
|
G |
Wasl |
WASP like actin nucleation promoting factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr 4:51,677,722...51,726,212
Ensembl chr 4:51,677,722...51,726,212
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
susceptibility |
ISO |
DNA:haploinsufficiency: : (mouse) |
RGD |
PMID:21737425 |
RGD:15036796 |
NCBI chr 1:81,412,635...81,441,680
Ensembl chr 1:81,413,353...81,441,678
|
|
G |
Xylb |
xylulokinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chr 8:128,041,875...128,076,951
Ensembl chr 8:128,044,084...128,076,946
|
|
G |
Zdhhc23 |
zinc finger DHHC-type palmitoyltransferase 23 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chr11:61,661,119...61,677,547
Ensembl chr11:61,661,310...61,676,684
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20216337 |
|
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18727619 |
|
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Adora1 |
adenosine A1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19019667 |
|
NCBI chr13:51,042,111...51,076,913
Ensembl chr13:51,042,248...51,076,852
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19019667 |
|
NCBI chr20:14,265,251...14,282,873
Ensembl chr20:14,265,252...14,282,873
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14616128 |
|
NCBI chr10:69,434,965...69,439,566
Ensembl chr10:69,434,941...69,439,575
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14616128 |
|
NCBI chr12:24,131,529...24,152,626
Ensembl chr12:24,148,567...24,152,625
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16630147 |
|
NCBI chr X:77,671,028...77,700,491
Ensembl chr X:77,674,150...77,700,269
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15970796 |
|
NCBI chr15:54,903,290...54,941,742
Ensembl chr15:54,905,274...54,906,203
|
|
G |
Faslg |
Fas ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19706026 |
|
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Fcer1a |
Fc fragment of IgE receptor Ia |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17125826 PMID:20485159 |
|
NCBI chr13:91,727,253...91,737,106
Ensembl chr13:91,730,925...91,737,053
|
|
G |
Fcer1g |
Fc fragment of IgE receptor Ig |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18534082 PMID:18595682 |
|
NCBI chr13:89,601,894...89,606,326
Ensembl chr13:89,601,896...89,606,326
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
susceptibility |
ISO |
DNA:deletion: : CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159, PMID:11007341 |
RGD:5491000 |
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
susceptibility |
ISO |
associated with Acquired Immunodeficiency Syndrome;DNA:polymorphism:exon:A>G313 (rs1695) (human) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159, PMID:16297214 |
RGD:5490995 |
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
susceptibility |
ISO |
DNA:deletion: : |
RGD |
PMID:11007341 |
RGD:5491000 |
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
Gzmb |
granzyme B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19706026 |
|
NCBI chr15:35,413,862...35,417,293
Ensembl chr15:35,413,793...35,417,316
|
|
G |
Hnmt |
histamine N-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chr 3:905,111...937,038
Ensembl chr 3:904,765...937,102
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16538175 |
|
NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779
|
|
G |
Hspa1l |
heat shock protein family A (Hsp70) member 1 like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16538175 |
|
NCBI chr20:4,879,998...4,965,191
Ensembl chr20:4,959,294...4,964,963
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19222424 PMID:20485159 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chr10:38,982,909...38,985,466
Ensembl chr10:38,982,909...38,985,466
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:1549655 |
RGD:8662975 |
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15867870 PMID:20485159 |
|
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chr 1:196,942,343...196,967,221
Ensembl chr 1:196,942,364...196,967,220
|
|
G |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16433794 |
|
NCBI chr10:35,736,486...35,743,088
Ensembl chr10:35,737,664...35,739,625
|
|
G |
Mln |
motilin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16538176 |
|
NCBI chr20:6,567,092...6,571,791
Ensembl chr20:6,567,092...6,571,791
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16839402 PMID:18534082 PMID:20485159 |
|
NCBI chr 1:227,957,363...227,965,312
Ensembl chr 1:227,957,302...227,965,386
|
|
G |
Nat2 |
N-acetyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 PMID:20602614 PMID:21572414 |
|
NCBI chr16:23,960,709...23,991,570
Ensembl chr16:23,961,067...23,991,570
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19767079 |
|
NCBI chr10:45,884,324...45,918,290
Ensembl chr10:45,893,018...45,918,254
|
|
G |
Postn |
periostin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18391768 |
|
NCBI chr 2:143,656,820...143,688,087
Ensembl chr 2:143,656,793...143,688,087
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20587336 |
|
NCBI chr 2:263,895,093...263,979,682
Ensembl chr 2:263,895,241...263,979,698
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17508966 |
|
NCBI chr 3:15,560,685...15,582,339
Ensembl chr 3:15,560,712...15,582,344
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chr20:4,087,621...4,097,190
Ensembl chr20:4,087,618...4,097,190
|
|
G |
Tac1 |
tachykinin, precursor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21233199 |
|
NCBI chr 4:33,638,853...33,646,819
Ensembl chr 4:33,638,709...33,646,819
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21449675 |
|
NCBI chr 4:66,624,181...66,846,745
Ensembl chr 4:66,670,618...66,846,805
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11294926 PMID:20485159 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19652058 |
|
NCBI chr15:51,433,853...51,464,215
|
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21055120 |
|
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apoc2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21055120 |
|
NCBI chr 1:80,589,023...80,593,991
Ensembl chr 1:80,589,023...80,594,136
|
|
G |
Apoc3 |
apolipoprotein C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21055120 |
|
NCBI chr 8:50,529,318...50,531,498
Ensembl chr 8:50,529,318...50,531,498
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
ISO |
mRNA:increased expression:lymph node, ear: |
RGD |
PMID:19904815 |
RGD:8657071 |
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
C4b |
complement C4B (Chido blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21055120 |
|
NCBI chr20:4,302,344...4,316,752
Ensembl chr20:4,302,344...4,316,715
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19351467 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
susceptibility |
ISO |
DNA:SNP: :Rs4244285(human) |
RGD |
PMID:23551241 |
RGD:11352742 |
NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19351467 |
|
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Fcer1a |
Fc fragment of IgE receptor Ia |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chr13:91,727,253...91,737,106
Ensembl chr13:91,730,925...91,737,053
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31150805 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31150805 |
|
NCBI chr 9:26,841,299...26,844,786
Ensembl chr 9:26,841,299...26,844,786
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18204966 |
|
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31150805 |
|
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19351467 |
|
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Kng2 |
kininogen 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:1371395 PMID:3034372 |
|
NCBI chr11:81,509,185...81,516,759
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18204966 |
|
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14723717 |
|
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31150805 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
susceptibility |
ISO |
DNA:polymorphisms:exon: |
RGD |
PMID:16836882 |
RGD:8547665 |
NCBI chr20:4,066,133...4,070,726
Ensembl chr20:4,066,132...4,070,721
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chr20:4,043,726...4,049,367
Ensembl chr20:4,039,413...4,049,711
|
|
G |
Tac1 |
tachykinin, precursor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1371395 |
|
NCBI chr 4:33,638,853...33,646,819
Ensembl chr 4:33,638,709...33,646,819
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31150805 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Ttr |
transthyretin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21055120 |
|
NCBI chr18:15,532,963...15,542,180
Ensembl chr18:15,532,963...15,540,177
|
|
|
G |
Hspa1l |
heat shock protein family A (Hsp70) member 1 like |
|
ISO |
DNA:polymorphism, haplotype: :p.M493T (human) |
RGD |
PMID:15024131 |
RGD:8662461 |
NCBI chr20:4,879,998...4,965,191
Ensembl chr20:4,959,294...4,964,963
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
DNA:SNP:promoter:-511C>T (rs 16944) (human) |
RGD |
PMID:23461376 |
RGD:11051970 |
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
DNA:SNP:intron:rs2234663 (human) |
RGD |
PMID:23461376 |
RGD:11051970 |
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
|
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
|
IMP |
|
RGD |
PMID:7740056, PMID:6445277 |
RGD:1598524, RGD:10047091 |
NCBI chr10:7,093,406...7,200,439
Ensembl chr10:7,093,405...7,200,499
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
|
IMP |
|
RGD |
PMID:18947822 |
RGD:6906919 |
NCBI chr16:6,110,294...6,405,022
Ensembl chr16:6,112,150...6,405,117
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19109989 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cck |
cholecystokinin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:2320253 |
|
NCBI chr 8:130,120,525...130,127,515
Ensembl chr 8:130,120,523...130,127,392
|
|
G |
Comt |
catechol-O-methyltransferase |
|
IMP |
|
RGD |
PMID:16437585 |
RGD:2289781 |
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
ISO |
|
RGD |
PMID:1673290 |
RGD:1358547 |
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
|
|
G |
Dbn1 |
drebrin 1 |
|
IEP |
levodopainduced; protein:increased expression:striatum: |
RGD |
PMID:23241013 |
RGD:10398811 |
NCBI chr17:9,679,511...9,693,878
Ensembl chr17:9,679,628...9,693,820
|
|
G |
Ddc |
dopa decarboxylase |
|
IEP |
associated with Parkinson Disease; protein:decreased expression:striatum (rat) |
RGD |
PMID:20232137 |
RGD:5128860 |
NCBI chr14:91,905,919...91,996,816
Ensembl chr14:91,905,919...91,996,774
|
|
G |
Drd1 |
dopamine receptor D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7845605 PMID:10858612 PMID:16982285 PMID:19520364 |
|
NCBI chr17:11,099,736...11,104,352
Ensembl chr17:11,101,306...11,103,541
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7845605 PMID:10534246 PMID:14629710, PMID:18707801 |
RGD:2311579 |
NCBI chr 8:53,678,777...53,743,643
Ensembl chr 8:53,678,777...53,743,642
|
|
G |
Drd3 |
dopamine receptor D3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20945430 |
|
NCBI chr11:61,819,102...61,883,223
Ensembl chr11:61,822,077...61,874,327
|
|
G |
Egr1 |
early growth response 1 |
|
IEP |
|
RGD |
PMID:22153973 |
RGD:10395307 |
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17219962 |
|
NCBI chr 1:80,214,691...80,221,417
Ensembl chr 1:80,214,494...80,221,710
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9767399 |
|
NCBI chr 3:56,861,440...56,902,139
Ensembl chr 3:56,861,396...56,902,157
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15659429 |
|
NCBI chr15:23,935,011...23,968,971
Ensembl chr15:23,934,585...23,969,011
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11168568 |
|
NCBI chr 2:56,884,181...56,912,964
Ensembl chr 2:56,887,987...56,910,238
|
|
G |
Glul |
glutamate-ammonia ligase |
|
IDA |
|
RGD |
PMID:6445277 |
RGD:10047091 |
NCBI chr13:71,331,052...71,340,207
Ensembl chr13:71,331,052...71,340,229
|
|
G |
Grk6 |
G protein-coupled receptor kinase 6 |
|
IMP |
associated with Parkinson Disease |
RGD |
PMID:20410529 |
RGD:5684919 |
NCBI chr17:9,705,917...9,721,921
Ensembl chr17:9,703,453...9,721,574
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
IMP |
associated with Parkinsonian Disorders |
RGD |
PMID:26997328 |
RGD:13792768 |
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
|
|
G |
Homer1 |
homer scaffold protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24126708 |
|
NCBI chr 2:22,909,550...23,012,303
Ensembl chr 2:22,909,569...23,009,678
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
|
IMP |
|
RGD |
PMID:21352823 |
RGD:5683628 |
NCBI chr 2:36,246,628...36,247,896
Ensembl chr 2:36,246,628...36,247,896
|
|
G |
Mapt |
microtubule-associated protein tau |
treatment |
IDA |
associated with Parkinsonian Disorders |
RGD |
PMID:25511986 |
RGD:13800920 |
NCBI chr10:92,289,002...92,386,517
Ensembl chr10:92,288,910...92,386,517
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
IMP |
associated with Parkinsonian Disorders |
RGD |
PMID:23938307 |
RGD:10040953 |
NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
|
|
G |
Pdyn |
prodynorphin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9767399 PMID:21737418 |
|
NCBI chr 3:122,194,327...122,206,671
Ensembl chr 3:122,194,329...122,206,671
|
|
G |
Penk |
proenkephalin |
|
IEP ISO |
mRNA:increased expression:brain:striatum: CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9767399, PMID:20456008 |
RGD:10003039 |
NCBI chr 5:17,056,412...17,061,762
Ensembl chr 5:17,056,419...17,061,837
|
|
G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
treatment |
IDA |
associated with Parkinsonian Disorders |
RGD |
PMID:27771532 |
RGD:13514053 |
NCBI chr10:86,303,727...86,312,770
Ensembl chr10:86,303,727...86,312,762
|
|
G |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21115823 |
|
NCBI chr 8:97,277,250...97,405,095
Ensembl chr 8:97,277,456...97,405,102
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
IEP |
protein:increased expression:nucleus, brain |
RGD |
PMID:18590723 |
RGD:2298778 |
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Rgs4 |
regulator of G-protein signaling 4 |
treatment |
IMP |
associated with Parkinsonian Disorders |
RGD |
PMID:24969021 |
RGD:13524515 |
NCBI chr13:88,054,817...88,061,108
Ensembl chr13:88,054,817...88,061,108
|
|
G |
Rgs9 |
regulator of G-protein signaling 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:18160641 PMID:24663062 |
|
NCBI chr10:97,509,971...97,582,188
Ensembl chr10:97,509,971...97,582,188
|
|
G |
Th |
tyrosine hydroxylase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15659429 |
|
NCBI chr 1:216,073,034...216,080,287
Ensembl chr 1:216,073,031...216,080,287
|
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IDA |
|
RGD |
PMID:29064425 |
RGD:13450913 |
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility no_association |
ISO |
DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human) DNA:SNPs:multiple: |
RGD |
PMID:17502832, PMID:22178260 |
RGD:14700816, RGD:14700817 |
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
IDA |
DNA:hypermethylation:promoter |
RGD |
PMID:23619520 |
RGD:14700910 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
IDA |
|
RGD |
PMID:16140414 |
RGD:2316848 |
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
|
|
G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
ISO |
protein:increased expression:liver (mouse) |
RGD |
PMID:12201952 |
RGD:10054288 |
NCBI chr 5:75,557,038...75,678,067
Ensembl chr 5:75,557,042...75,676,584
|
|
G |
Mir22 |
microRNA 22 |
|
ISO |
in male; RNA:increased expression:liver: |
RGD |
PMID:21750200 |
RGD:14700876 |
NCBI chr10:62,299,592...62,299,686
Ensembl chr10:62,299,592...62,299,686
|
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
ISO |
ClinVar Annotator: match by term: Efavirenz, poor metabolism of |
OMIM ClinVar |
PMID:15194512 PMID:15622315 PMID:15864119 PMID:16267764 PMID:17235330 PMID:17559344 PMID:18281305 PMID:19228205 PMID:19371316 PMID:19659438 PMID:19779319 PMID:20338069 PMID:20441246 PMID:20625352 PMID:20639527 PMID:20723261 PMID:20860463 PMID:20952418 PMID:21393201 PMID:21441248 PMID:21715435 PMID:21790905 PMID:21824325 PMID:21860339 PMID:21862974 PMID:21902500 PMID:22057858 PMID:22111602 PMID:22354160 PMID:22471906 PMID:22680342 PMID:22927450 PMID:22992668 PMID:23080225 PMID:23172109 PMID:23254426 PMID:23399569 PMID:23418033 PMID:23640958 PMID:23734829 PMID:23778320 PMID:23846872 PMID:23859571 PMID:23970651 PMID:23982262 PMID:23996099 PMID:24080498 PMID:24142869 PMID:24145522 PMID:24217698 PMID:24316028 PMID:24497997 PMID:24517233 PMID:24551111 PMID:24956253 PMID:25303294 PMID:25456329 PMID:25556837 PMID:25611810 PMID:25669165 PMID:26196596 PMID:26774523 PMID:26779253 PMID:27299708 PMID:27655857 PMID:28886044 PMID:29624706 |
|
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
|
|
|
G |
C3 |
complement C3 |
|
ISO |
associated with Leprosy |
RGD |
PMID:2783924 |
RGD:7421527 |
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
Cfb |
complement factor B |
|
ISO |
associated with Leprosy |
RGD |
PMID:2783924 |
RGD:7421527 |
NCBI chr20:4,536,206...4,542,073
Ensembl chr20:4,536,203...4,561,066 Ensembl chr20:4,536,203...4,561,066
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
susceptibility |
ISO |
associated with Behcet Syndrome;DNA:deletion:: (human) |
RGD |
PMID:22766250 |
RGD:7794848 |
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Lta |
lymphotoxin alpha |
|
ISO |
associated with Sarcoidosis;DNA:polymorphism:intron |
RGD |
PMID:19225544 |
RGD:8548773 |
NCBI chr20:4,851,889...4,854,677
Ensembl chr20:4,852,496...4,854,677
|
|
G |
RT1-CE13 |
RT1 class I, locus CE13 |
|
ISO |
associated with Inflammatory Bowel Diseases; DNA:polymorphisms:cds:multiple (human) |
RGD |
PMID:12198697 |
RGD:7364926 |
|
|
G |
Tnf |
tumor necrosis factor |
susceptibility |
ISO |
associated with Inflammatory Bowel Diseases;DNA:polymorphisms: :-1031T>C(human) |
RGD |
PMID:12198697 |
RGD:7364926 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Vdr |
vitamin D receptor |
susceptibility |
ISO |
associated with Behcet Syndrome;DNA:polymorphism: : rs7975232(human) |
RGD |
PMID:24880677 |
RGD:13217417 |
NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166
|
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
IEP |
|
RGD |
PMID:28921207 |
RGD:14975164 |
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
|
|
|
G |
Kdr |
kinase insert domain receptor |
treatment |
ISO |
DNA:polymorphism:cds:p.H472Q(human) |
RGD |
PMID:20630084 |
RGD:8552374 |
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
|
|
|
G |
Casp9 |
caspase 9 |
|
IEP |
|
RGD |
PMID:25014874 |
RGD:13782349 |
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
treatment |
IMP |
|
RGD |
PMID:11991626 |
RGD:10003093 |
NCBI chr 2:263,895,093...263,979,682
Ensembl chr 2:263,895,241...263,979,698
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
treatment |
IMP |
|
RGD |
PMID:11991626 |
RGD:10003093 |
NCBI chr 2:54,951,625...54,966,470
Ensembl chr 2:54,952,821...54,963,448
|
|
|
G |
Tpmt |
thiopurine S-methyltransferase |
|
ISO |
|
OMIM |
|
|
NCBI chr17:18,029,090...18,047,716
Ensembl chr17:18,029,124...18,047,714
|
|
|
G |
Nudt15 |
nudix hydrolase 15 |
|
ISO |
ClinVar Annotator: match by term: THIOPURINES, POOR METABOLISM OF, 2 ClinVar Annotator: match by term: Thiopurines, poor metabolism of, 2 |
ClinVar OMIM |
PMID:22992668 PMID:25108385 PMID:25624441 PMID:26033531 PMID:26076924 PMID:26405151 PMID:26503813 PMID:26590936 PMID:26735160 PMID:26878724 PMID:27095468 PMID:27193222 PMID:27381176 PMID:27416873 PMID:27530327 PMID:27558924 PMID:27577869 PMID:27604507 PMID:28088792 PMID:28146264 |
|
NCBI chr15:55,417,774...55,456,698
Ensembl chr15:55,419,502...55,456,698
|
|
|
G |
Cabp1 |
calcium binding protein 1 |
|
IEP |
protein:altered expression:postsynaptic density |
RGD |
PMID:19224364 |
RGD:14399959 |
NCBI chr12:47,185,449...47,209,785
Ensembl chr12:47,179,664...47,209,784
|
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:350256 PMID:9380243 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12239465 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chr17:75,259,269...75,660,154
Ensembl chr17:75,352,389...75,654,951
|
|
G |
Clu |
clusterin |
|
ISO |
mRNA:decreased expression:conjunctiva |
RGD |
PMID:12036968 |
|